Mettler-Toledo International (NYSE:MTD – Get Free Report) and OmniAb (NASDAQ:OABI – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Mettler-Toledo International and OmniAb, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mettler-Toledo International | 1 | 8 | 6 | 0 | 2.33 |
| OmniAb | 1 | 0 | 3 | 0 | 2.50 |
Mettler-Toledo International presently has a consensus target price of $1,469.15, indicating a potential downside of 14.75%. OmniAb has a consensus target price of $11.50, indicating a potential upside of 128.63%. Given OmniAb’s stronger consensus rating and higher possible upside, analysts clearly believe OmniAb is more favorable than Mettler-Toledo International.
Institutional & Insider Ownership
95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 72.1% of OmniAb shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by insiders. Comparatively, 9.8% of OmniAb shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Mettler-Toledo International and OmniAb’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mettler-Toledo International | 21.91% | -1,212.14% | 25.11% |
| OmniAb | -108.11% | -16.74% | -14.79% |
Earnings & Valuation
This table compares Mettler-Toledo International and OmniAb”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mettler-Toledo International | $4.03 billion | 8.58 | $869.19 million | $44.43 | 38.79 |
| OmniAb | $18.67 million | 39.01 | -$64.78 million | ($0.34) | -14.79 |
Mettler-Toledo International has higher revenue and earnings than OmniAb. OmniAb is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Mettler-Toledo International has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, OmniAb has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500.
Summary
Mettler-Toledo International beats OmniAb on 9 of the 14 factors compared between the two stocks.
About Mettler-Toledo International
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company’s retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.
About OmniAb
OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
